Sildenafil Citrate/Clomipramine Hydrochloride

枸橼酸西地那非/盐酸氯米帕明

Report date: 2024/05/20 15:49:22

Base Information

Drug NameSildenafil Citrate/Clomipramine Hydrochloride
Drug Alias Name枸橼酸西地那非-盐酸氯米帕明Sildenafil Citrate/Clomipramine枸橼酸西地那非+盐酸氯米帕明Sildenafil/Clomipramine HydrochlorideSildenafil Citrate+Clomipramine Hydrochloride +[15] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin reuptake inhibitorsNorepinephrine reuptake inhibitorsPhosphodiesterase 5A inhibitors
TargetsNorepinephrine transporterPhosphodiesterase 5ASerotonin transporter
Therapy Area/IndicationsPremature Ejaculation
Global Approved IndicationsPremature Ejaculation
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2024/05/17
Country/TerritorySouth Korea
CombinationsYes Sildenafil CitrateClomipramine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCtc Bio America Inc
China Registration ClassN/A

Develop Information

Active CompaniesCtc BioDongkoo Bio & Pharma
Inactive CompaniesCtcbio Inc
Active IndicationsPremature Ejaculation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A